Karl-Erik Andersson to Benzhydryl Compounds
This is a "connection" page, showing publications Karl-Erik Andersson has written about Benzhydryl Compounds.
Connection Strength
1.314
-
Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. J Urol. 2010 Aug; 184(2):783-9.
Score: 0.320
-
Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction. BJU Int. 2010 Jul; 106(2):287-93.
Score: 0.306
-
Ney P, Pandita RK, Newgreen DT, Breidenbach A, Stöhr T, Andersson KE. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. BJU Int. 2008 Apr; 101(8):1036-42.
Score: 0.272
-
Hedlund P, Streng T, Lee T, Andersson KE. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. J Urol. 2007 Jul; 178(1):326-31.
Score: 0.258
-
Streng T, Andersson KE, Hedlund P, Gratzke C, Baroni E, D'Ambrosio D, Benigni F. Effects on bladder function of combining elocalcitol and tolterodine in rats with outflow obstruction. BJU Int. 2012 Jul; 110(2 Pt 2):E125-31.
Score: 0.089
-
Andersson KE. How many drugs for LUTS due to BPH are too many? J Urol. 2008 Sep; 180(3):811-2.
Score: 0.070